Jonathan Milner News Today

Cambridge Cluster Life Sciences companies continue to grow stronger and more globally influential and have the opportunity to demonstrate their turnkey excellence in the 2023-24 Business Weekly Awards.

After a slow start to 2023 in an uncertain economic climate, biopharma mergers and acquisitions are on the rise.

Life sciences startup Nuclera has said it is eyeing up a public listing in New York in the next five years as it approaches unicorn status. 

Studio71 has signed an advertising partnership with Unspeakable, a popular family-friendly content creator on YouTube.

Studio71 has signed an advertising partnership with Unspeakable, a popular family-friendly content creator on YouTube who has more than 33 million subscribers…

Medical tools supplier Danaher said on Wednesday it has completed the $5.7 billion acquisition of Abcam, overcoming the initial opposition from the founder of the protein consumables maker. ...

The founder of Abcam has ended a campaign to block the $5.7 billion takeover of the British life sciences company after conceding that most shareholders plan to

/PRNewswire/ -- Invizius Limited ("Invizius"), a biotechnology company developing breakthrough treatments for patients on dialysis, is pleased to announce the...

Jonathan Milner, who founded Abcam in 1998, is desperately trying to halt a bit by conglomerate Danaher in a £4.7 billion buyout.

By John Jannarone Perhaps Glass Lewis knows multiplication better than more prominent proxy advisor Institutional Shareholder Services. Medical supplies behemoth Danaher Corp. is making a move to acquire Abcam plc (ABCM) for $24 a share in cold hard cash. Trouble is, the company continues to say it may be worth quite a bit more. In […] The post She Blinded Me with Science – ISS Makes Schoolboy Error on Abcam Deal appeared first on CorpGov.